Kovial Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Revenue Growth 582.38%
- Profit Growth 30694.17%
- Ebitda 89495.74%
- Net Worth 188.83%
- Total Assets 20656.06%
About Kovial Biotech
Kovial Biotech Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2021 (Three years and seven months 10 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Pushpendra Singh and Parvindra Kumar serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100HP2021PTC008643
-
Company No.
008643
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Kovial Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpendra Singh
|
Director | 25-Jun-2021 | Current |
|
Parvindra Kumar
|
Director | 25-Jun-2021 | Current |
Financial Performance of Kovial Biotech.
Kovial Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 582.38% increase. The company also saw a substantial improvement in profitability, with a 30694.17% increase in profit. The company's net worth Soared by an impressive increase of 188.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kovial Biotech?
Unlock access to Kovial Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Astrofine Pharma Private LimitedPushpendra Singh is a mutual person
-
Sunfine Healthcare Private Limited
Pushpendra Singh and Parvindra Kumar are mutual person
-
Yesplast Private Limited
Parvindra Kumar is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2023 | State Bank Of India | ₹2.00 Cr | Open |
How Many Employees Work at Kovial Biotech?
Unlock and access historical data on people associated with Kovial Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kovial Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kovial Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.